The Sanofi French pharmaceutical group hopes to have the COVID-19 vaccine available for December.
Its president for France, Olivier Bogillot, explained Monday in an interview with the France Inter station that this vaccine (in double dose) uses the same technology that is already used for the flu vaccine, not that of the messenger RNA."It is a technology proven for years" that is based on a recombinant protein with an adjuvant that stimulates the immune system, he said.
In spite.
How to take care of shin ryujin well: 1. Give her lots of compliments 2. Give her lots of love 3.Feed Her Well ... https: // t.CO/YMPGRKWUA0
— 🌼byul🌼 Sat Jul 24 05:15:26 +0000 2021
First because even in France a part of citizens are not yet vaccinated, because a high percentage will have to be achieved to achieve collective immunity and because there are still great needs worldwide, since for now only 20 % have received at least a dose.In addition, he was convinced that a third memory dose will have to be administered.
The French Secretary of State for Consumer.
Pannier-Runacher, who stressed that the results of the phase 2 tests had been excellent, stressed that the product developed by Sanofi has some virtues that can make it useful especially in developing countries since it is preserved in a refrigerator and ischeaper than technology vaccines arn messenger.